An analytic framework to develop policies for testing, prevention, and treatment of two-stage contagious diseases

In this paper we consider healthcare policy issues for trading off resources in testing, prevention, and cure of two-stage contagious diseases. An individual that has contracted the two-stage contagious disease will initially show no symptoms of the disease but is capable of spreading it. If the initial stages are not detected which could lead to complications eventually, then symptoms start appearing in the latter stage when it would be necessary to perform expensive treatment. Under a constrained budget situation, policymakers are faced with the decision of how to allocate budget for prevention (via vaccinations), subsidizing treatment, and examination to detect the presence of initial stages of the contagious disease. These decisions need to be performed in each period of a given time horizon. To aid this decision-making exercise, we formulate a stochastic dynamic optimal control problem with feedback which can be modeled as a Markov decision process (MDP). However, solving the MDP is computationally intractable due to the large state space as the embedded stochastic network cannot be decomposed. Hence we propose an asymptotically optimal solution based on a fluid model of the dynamics in the stochastic network. We heuristically fine-tune the asymptotically optimal solution for the non-asymptotic case, and test it extensively for several numerical cases. In particular we investigate the effect of budget, length of planning horizon, type of disease, population size, and ratio of costs on the policy for budget allocation.

[1]  Lawrence M. Wein,et al.  Pooled Testing for HIV Screening: Capturing the Dilution Effect , 2018, Oper. Res..

[2]  Sue J Goldie,et al.  Health and economic implications of HPV vaccination in the United States. , 2008, The New England journal of medicine.

[3]  J. Banks,et al.  Discrete-Event System Simulation , 1995 .

[4]  M. Newman Spread of epidemic disease on networks. , 2002, Physical review. E, Statistical, nonlinear, and soft matter physics.

[5]  H. Andersson,et al.  Stochastic Epidemic Models and Their Statistical Analysis , 2000 .

[6]  A. J. Hall Infectious diseases of humans: R. M. Anderson & R. M. May. Oxford etc.: Oxford University Press, 1991. viii + 757 pp. Price £50. ISBN 0-19-854599-1 , 1992 .

[7]  Darrell Whitley,et al.  A genetic algorithm tutorial , 1994, Statistics and Computing.

[8]  Herbert W. Hethcote,et al.  The Mathematics of Infectious Diseases , 2000, SIAM Rev..

[9]  W. O. Kermack,et al.  A contribution to the mathematical theory of epidemics , 1927 .

[10]  Alan S. Perelson,et al.  Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..

[11]  Erik J. Dasbach,et al.  Model for Assessing Human Papillomavirus Vaccination Strategies , 2007, Emerging infectious diseases.

[12]  Basil Donovan,et al.  Evaluating human papillomavirus vaccination programs. , 2013, Sexually transmitted diseases.

[13]  Martin A Nowak,et al.  Mathematical models of HIV pathogenesis and treatment. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  D. Whynes,et al.  Stage-specific treatment costs for cervical cancer in the United Kingdom. , 1998, European journal of cancer.

[15]  N. Ling The Mathematical Theory of Infectious Diseases and its applications , 1978 .

[16]  J. Robins,et al.  Transmission Dynamics and Control of Severe Acute Respiratory Syndrome , 2003, Science.

[17]  A. M'Kendrick Applications of Mathematics to Medical Problems , 1925, Proceedings of the Edinburgh Mathematical Society.

[18]  N. Bäuerle Asymptotic optimality of tracking policies in stochastic networks , 2001 .

[19]  Alexander Grey,et al.  The Mathematical Theory of Infectious Diseases and Its Applications , 1977 .

[20]  Sue J Goldie,et al.  Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. , 2006, Vaccine.

[21]  Fangjun Zhou,et al.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact. , 2005, International journal of epidemiology.

[22]  P. Kaye Infectious diseases of humans: Dynamics and control , 1993 .

[23]  Ronald H Gray,et al.  Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda , 2003, AIDS.

[24]  Geni Gupur,et al.  Analysis of an Age Structured SEIRS Epidemic Model with Varying Total Population Size and Vaccination , 2004 .

[25]  M. S. Bartlett,et al.  Some Evolutionary Stochastic Processes , 1949 .

[26]  Kendrick,et al.  Applications of Mathematics to Medical Problems , 1925, Proceedings of the Edinburgh Mathematical Society.

[27]  Alan S. Perelson,et al.  Optimization of Influenza Vaccine Selection , 2005, Oper. Res..

[28]  Martin L. Puterman,et al.  Markov Decision Processes: Discrete Stochastic Dynamic Programming , 1994 .

[29]  GeniGupur,et al.  Analysis of an Age Structured SEIRS Epidemic Model with Varying Total Population Size and Vaccination , 2004 .

[30]  Jean-Pierre Gabriel,et al.  Stochastic Processes in Epidemic Theory , 1990 .